| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth | 33 | 2016 | 152 | 6.580 |
Why?
|
| Tissue Engineering | 26 | 2019 | 700 | 5.930 |
Why?
|
| Anal Canal | 14 | 2019 | 35 | 4.240 |
Why?
|
| Myocytes, Smooth Muscle | 19 | 2017 | 95 | 3.590 |
Why?
|
| Gastrointestinal Tract | 8 | 2019 | 41 | 3.060 |
Why?
|
| Colon | 16 | 2012 | 71 | 2.750 |
Why?
|
| Muscle Contraction | 21 | 2015 | 183 | 2.670 |
Why?
|
| Bioengineering | 9 | 2019 | 77 | 1.890 |
Why?
|
| Fecal Incontinence | 8 | 2019 | 32 | 1.880 |
Why?
|
| Regenerative Medicine | 9 | 2019 | 219 | 1.730 |
Why?
|
| Tissue Scaffolds | 12 | 2019 | 435 | 1.650 |
Why?
|
| Rabbits | 22 | 2017 | 231 | 1.620 |
Why?
|
| Animals | 49 | 2019 | 8544 | 1.520 |
Why?
|
| Gastrointestinal Diseases | 5 | 2015 | 51 | 1.480 |
Why?
|
| Enteric Nervous System | 4 | 2015 | 5 | 1.390 |
Why?
|
| Stem Cells | 6 | 2019 | 331 | 1.360 |
Why?
|
| Regeneration | 4 | 2019 | 179 | 1.360 |
Why?
|
| Cells, Cultured | 20 | 2017 | 887 | 1.250 |
Why?
|
| Chitosan | 3 | 2015 | 6 | 1.240 |
Why?
|
| Intestines | 5 | 2013 | 65 | 1.220 |
Why?
|
| Muscle Relaxation | 7 | 2011 | 21 | 1.200 |
Why?
|
| Tropomyosin | 7 | 2010 | 10 | 1.180 |
Why?
|
| Protein Kinase C | 7 | 2005 | 43 | 1.140 |
Why?
|
| Acetylcholine | 16 | 2015 | 69 | 1.090 |
Why?
|
| Neurons | 4 | 2015 | 491 | 1.060 |
Why?
|
| rhoA GTP-Binding Protein | 6 | 2009 | 13 | 1.020 |
Why?
|
| Protein Kinase C-alpha | 10 | 2009 | 15 | 1.020 |
Why?
|
| Heat-Shock Proteins | 6 | 2005 | 44 | 0.940 |
Why?
|
| Phosphorylation | 15 | 2010 | 264 | 0.890 |
Why?
|
| Cell Differentiation | 3 | 2015 | 484 | 0.860 |
Why?
|
| Gastrointestinal Motility | 8 | 2014 | 11 | 0.840 |
Why?
|
| Aging | 6 | 2011 | 1010 | 0.820 |
Why?
|
| Signal Transduction | 8 | 2010 | 765 | 0.760 |
Why?
|
| Calmodulin-Binding Proteins | 4 | 2010 | 4 | 0.730 |
Why?
|
| Microfilament Proteins | 5 | 2009 | 38 | 0.710 |
Why?
|
| Intestine, Small | 3 | 2017 | 43 | 0.660 |
Why?
|
| HSP20 Heat-Shock Proteins | 2 | 2010 | 2 | 0.620 |
Why?
|
| Caveolin 1 | 2 | 2011 | 15 | 0.600 |
Why?
|
| Pylorus | 2 | 2015 | 7 | 0.590 |
Why?
|
| Bioprosthesis | 1 | 2019 | 62 | 0.590 |
Why?
|
| Antigens, Differentiation | 2 | 2015 | 27 | 0.590 |
Why?
|
| Protein-Serine-Threonine Kinases | 5 | 2007 | 57 | 0.580 |
Why?
|
| Neoplasm Proteins | 3 | 2004 | 155 | 0.560 |
Why?
|
| Tissue Transplantation | 2 | 2015 | 17 | 0.560 |
Why?
|
| Humans | 33 | 2019 | 34474 | 0.560 |
Why?
|
| Esophagogastric Junction | 2 | 2016 | 10 | 0.550 |
Why?
|
| Calcium-Binding Proteins | 3 | 2008 | 49 | 0.540 |
Why?
|
| Neurogenesis | 2 | 2015 | 17 | 0.540 |
Why?
|
| Neuromuscular Diseases | 2 | 2014 | 17 | 0.530 |
Why?
|
| Implants, Experimental | 1 | 2016 | 13 | 0.510 |
Why?
|
| Vasoactive Intestinal Peptide | 5 | 2015 | 9 | 0.450 |
Why?
|
| Appendix | 1 | 2015 | 6 | 0.450 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 260 | 0.430 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 45 | 0.420 |
Why?
|
| Nerve Regeneration | 1 | 2014 | 51 | 0.410 |
Why?
|
| Electric Stimulation | 4 | 2015 | 139 | 0.400 |
Why?
|
| Rats | 6 | 2016 | 1946 | 0.370 |
Why?
|
| Rats, Nude | 3 | 2017 | 48 | 0.350 |
Why?
|
| Bioartificial Organs | 1 | 2011 | 26 | 0.340 |
Why?
|
| Models, Animal | 3 | 2017 | 198 | 0.330 |
Why?
|
| Contractile Proteins | 3 | 2009 | 5 | 0.330 |
Why?
|
| Transfection | 5 | 2011 | 216 | 0.330 |
Why?
|
| Artificial Organs | 1 | 2010 | 14 | 0.320 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 53 | 0.310 |
Why?
|
| Muscle Proteins | 4 | 2009 | 69 | 0.310 |
Why?
|
| Graft Survival | 1 | 2011 | 315 | 0.310 |
Why?
|
| Stem Cell Transplantation | 3 | 2019 | 228 | 0.300 |
Why?
|
| Organ Culture Techniques | 3 | 2017 | 44 | 0.300 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 20 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2007 | 86 | 0.260 |
Why?
|
| Digestive System Physiological Phenomena | 2 | 2003 | 2 | 0.250 |
Why?
|
| rho-Associated Kinases | 4 | 2009 | 16 | 0.250 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 593 | 0.250 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2011 | 124 | 0.250 |
Why?
|
| Protein Binding | 4 | 2009 | 255 | 0.250 |
Why?
|
| Digestive System | 2 | 2003 | 5 | 0.250 |
Why?
|
| HSP27 Heat-Shock Proteins | 3 | 2010 | 6 | 0.240 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2005 | 3 | 0.240 |
Why?
|
| Enzyme Inhibitors | 7 | 2011 | 185 | 0.230 |
Why?
|
| Prosthesis Implantation | 2 | 2019 | 41 | 0.230 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 103 | 0.220 |
Why?
|
| Muscle Development | 2 | 2015 | 52 | 0.220 |
Why?
|
| Actins | 3 | 2008 | 56 | 0.220 |
Why?
|
| Calcium | 4 | 2010 | 343 | 0.210 |
Why?
|
| Time Factors | 5 | 2011 | 2352 | 0.210 |
Why?
|
| Myosin Light Chains | 3 | 2010 | 5 | 0.210 |
Why?
|
| Protein Transport | 3 | 2011 | 82 | 0.190 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 2011 | 21 | 0.190 |
Why?
|
| Myosins | 1 | 2002 | 12 | 0.190 |
Why?
|
| Biocompatible Materials | 3 | 2013 | 242 | 0.180 |
Why?
|
| Sphingosine | 1 | 2002 | 14 | 0.180 |
Why?
|
| Esophagus | 3 | 2013 | 30 | 0.170 |
Why?
|
| Mice | 7 | 2011 | 2691 | 0.170 |
Why?
|
| Feasibility Studies | 2 | 2013 | 323 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 1118 | 0.160 |
Why?
|
| Neovascularization, Physiologic | 2 | 2011 | 118 | 0.160 |
Why?
|
| Naphthalenes | 3 | 2005 | 53 | 0.160 |
Why?
|
| Precipitin Tests | 3 | 2004 | 21 | 0.150 |
Why?
|
| Male | 6 | 2019 | 20697 | 0.150 |
Why?
|
| Recombinant Proteins | 3 | 2004 | 281 | 0.150 |
Why?
|
| Pressure | 2 | 2016 | 70 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2008 | 10 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 526 | 0.140 |
Why?
|
| Intestinal Mucosa | 2 | 2012 | 75 | 0.140 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 548 | 0.140 |
Why?
|
| Asthma | 3 | 2009 | 274 | 0.130 |
Why?
|
| Reflex | 1 | 2017 | 21 | 0.130 |
Why?
|
| Omentum | 1 | 2017 | 26 | 0.130 |
Why?
|
| Receptors, Cholinergic | 1 | 2017 | 26 | 0.130 |
Why?
|
| Mutation | 3 | 2011 | 529 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 118 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2010 | 328 | 0.130 |
Why?
|
| Tensile Strength | 1 | 2016 | 59 | 0.130 |
Why?
|
| Bronchi | 2 | 2008 | 41 | 0.130 |
Why?
|
| Hypertrophy | 4 | 2009 | 36 | 0.120 |
Why?
|
| Stomach | 2 | 2013 | 19 | 0.120 |
Why?
|
| Pyridines | 3 | 2005 | 87 | 0.120 |
Why?
|
| Collagen | 2 | 2014 | 239 | 0.120 |
Why?
|
| Tetrodotoxin | 1 | 2015 | 14 | 0.120 |
Why?
|
| Phenotype | 2 | 2015 | 656 | 0.120 |
Why?
|
| Female | 7 | 2017 | 21490 | 0.110 |
Why?
|
| Organoids | 1 | 2016 | 99 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2015 | 14 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 22 | 0.110 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 53 | 0.110 |
Why?
|
| Nitrates | 1 | 2015 | 29 | 0.110 |
Why?
|
| Hirschsprung Disease | 1 | 2014 | 1 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 42 | 0.110 |
Why?
|
| Models, Biological | 2 | 2009 | 426 | 0.110 |
Why?
|
| Vasodilation | 1 | 2015 | 96 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2015 | 148 | 0.110 |
Why?
|
| Biofeedback, Psychology | 1 | 2014 | 12 | 0.110 |
Why?
|
| Motor Neurons | 1 | 2015 | 65 | 0.110 |
Why?
|
| Cell Separation | 1 | 2015 | 93 | 0.110 |
Why?
|
| Heparitin Sulfate | 1 | 2014 | 3 | 0.110 |
Why?
|
| Vasodilator Agents | 2 | 2005 | 69 | 0.110 |
Why?
|
| Laminin | 1 | 2014 | 16 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 45 | 0.100 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 27 | 0.100 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 39 | 0.100 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 80 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 183 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2011 | 834 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 304 | 0.100 |
Why?
|
| Adult Stem Cells | 1 | 2013 | 26 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2013 | 116 | 0.100 |
Why?
|
| Muscles | 1 | 2013 | 67 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2014 | 251 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 3 | 2009 | 67 | 0.090 |
Why?
|
| Nerve Net | 1 | 2013 | 141 | 0.090 |
Why?
|
| Porosity | 1 | 2012 | 41 | 0.090 |
Why?
|
| Tissue Expansion | 1 | 2012 | 6 | 0.090 |
Why?
|
| Jejunum | 1 | 2012 | 8 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 106 | 0.090 |
Why?
|
| Exercise Therapy | 1 | 2014 | 283 | 0.090 |
Why?
|
| Short Bowel Syndrome | 1 | 2012 | 13 | 0.090 |
Why?
|
| General Surgery | 1 | 2012 | 85 | 0.090 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cholinergic Agonists | 1 | 2011 | 7 | 0.090 |
Why?
|
| Hormone Antagonists | 1 | 2011 | 7 | 0.090 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2011 | 2 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 43 | 0.080 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2011 | 16 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 22 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 123 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2011 | 86 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 55 | 0.080 |
Why?
|
| Culture Media | 1 | 2010 | 50 | 0.080 |
Why?
|
| Lung | 2 | 2009 | 279 | 0.080 |
Why?
|
| Stimulation, Chemical | 1 | 2010 | 16 | 0.080 |
Why?
|
| Infusion Pumps | 1 | 2010 | 9 | 0.080 |
Why?
|
| Muscle Tonus | 1 | 2010 | 7 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 118 | 0.080 |
Why?
|
| Muscle Strength | 1 | 2011 | 157 | 0.080 |
Why?
|
| Cell Enlargement | 1 | 2009 | 1 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2009 | 2 | 0.080 |
Why?
|
| Airway Remodeling | 1 | 2009 | 5 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2011 | 484 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2009 | 148 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 755 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 508 | 0.080 |
Why?
|
| Enzyme Activators | 1 | 2009 | 8 | 0.070 |
Why?
|
| Caveolae | 1 | 2009 | 4 | 0.070 |
Why?
|
| Fibrin | 1 | 2009 | 33 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2008 | 42 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 91 | 0.070 |
Why?
|
| Quality of Life | 1 | 2014 | 1032 | 0.070 |
Why?
|
| Pneumonia | 1 | 2008 | 70 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2008 | 57 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2005 | 71 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1261 | 0.070 |
Why?
|
| Actomyosin | 2 | 2005 | 3 | 0.070 |
Why?
|
| Gene Expression | 2 | 2005 | 362 | 0.060 |
Why?
|
| Amides | 1 | 2005 | 30 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2005 | 41 | 0.060 |
Why?
|
| Binding Sites | 1 | 2005 | 150 | 0.060 |
Why?
|
| Kinetics | 1 | 2005 | 259 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2004 | 1 | 0.050 |
Why?
|
| Serine | 1 | 2004 | 11 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2004 | 48 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2004 | 31 | 0.050 |
Why?
|
| Biological Transport | 1 | 2004 | 76 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 87 | 0.050 |
Why?
|
| Antibodies | 1 | 2004 | 59 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 12 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 319 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2003 | 111 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 66 | 0.050 |
Why?
|
| Adult | 2 | 2014 | 10015 | 0.050 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Liver Transplantation | 2 | 2012 | 185 | 0.040 |
Why?
|
| Ovalbumin | 2 | 2009 | 6 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 201 | 0.040 |
Why?
|
| Cell Size | 2 | 2008 | 43 | 0.030 |
Why?
|
| Cytokines | 2 | 2009 | 269 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 44 | 0.030 |
Why?
|
| Antidiarrheals | 1 | 2014 | 1 | 0.030 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2014 | 5 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2005 | 54 | 0.030 |
Why?
|
| Flavonoids | 2 | 2004 | 21 | 0.030 |
Why?
|
| Peristalsis | 1 | 2012 | 2 | 0.020 |
Why?
|
| Absorption | 1 | 2012 | 16 | 0.020 |
Why?
|
| Larynx | 1 | 2012 | 21 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2012 | 23 | 0.020 |
Why?
|
| Disaccharidases | 1 | 2012 | 1 | 0.020 |
Why?
|
| Skin, Artificial | 1 | 2012 | 34 | 0.020 |
Why?
|
| Ion Transport | 1 | 2012 | 6 | 0.020 |
Why?
|
| Tissue Expansion Devices | 1 | 2012 | 12 | 0.020 |
Why?
|
| Pancreatic Diseases | 1 | 2012 | 21 | 0.020 |
Why?
|
| Aged | 1 | 2005 | 10998 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 39 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2012 | 21 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 17 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2012 | 25 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2012 | 65 | 0.020 |
Why?
|
| Liver Failure | 1 | 2012 | 22 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2012 | 87 | 0.020 |
Why?
|
| Swine | 1 | 2012 | 230 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 236 | 0.020 |
Why?
|
| Organ Transplantation | 1 | 2012 | 67 | 0.020 |
Why?
|
| Wound Healing | 1 | 2012 | 190 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 2010 | 28 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 44 | 0.020 |
Why?
|
| Manometry | 1 | 2010 | 24 | 0.020 |
Why?
|
| Ribosomal Protein S6 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2009 | 8 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 242 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2010 | 116 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 46 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 628 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 79 | 0.020 |
Why?
|
| Respiratory System | 1 | 2008 | 11 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 36 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 98 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 197 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 2008 | 2 | 0.020 |
Why?
|
| Lithium Chloride | 1 | 2008 | 3 | 0.020 |
Why?
|
| Maleimides | 1 | 2008 | 8 | 0.020 |
Why?
|
| Indoles | 1 | 2008 | 67 | 0.020 |
Why?
|
| Parity | 1 | 2007 | 21 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 548 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 118 | 0.020 |
Why?
|
| Chromones | 1 | 2005 | 6 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2005 | 12 | 0.010 |
Why?
|
| United States | 1 | 2014 | 4267 | 0.010 |
Why?
|
| Morpholines | 1 | 2005 | 46 | 0.010 |
Why?
|
| Heart Failure | 1 | 2012 | 780 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2005 | 149 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2004 | 2 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2004 | 12 | 0.010 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 14 | 0.010 |
Why?
|
| Tyrosine | 1 | 2004 | 28 | 0.010 |
Why?
|
| Pregnancy | 1 | 2007 | 1069 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2004 | 123 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 2003 | 8 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 41 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 46 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 39 | 0.010 |
Why?
|
| Cats | 1 | 2003 | 136 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 1603 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 97 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 545 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 1386 | 0.010 |
Why?
|
| Middle Aged | 1 | 2007 | 12703 | 0.010 |
Why?
|